Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Vikram Mavinkurve"'
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Time from prior treatment to start of treatment within this protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b927245209896f51adadd25522b2cb
https://doi.org/10.1158/1078-0432.22476701.v1
https://doi.org/10.1158/1078-0432.22476701.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Additional description of correlative immunologic assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b73548f2b930487c0bf75cdb08bf0b1
https://doi.org/10.1158/1078-0432.22476704.v1
https://doi.org/10.1158/1078-0432.22476704.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Absolute numbers (absolute lymphocyte count * proportion) of designated cell populations at pre-treatment baseline (V1); after the completion of RT/prior to the 3rd dose of immunotherapy (week 6-9, V2); and at the timepoint of first radiographic asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6460880c4dee4517ba7db2a204562a53
https://doi.org/10.1158/1078-0432.22476710
https://doi.org/10.1158/1078-0432.22476710
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Levels of eotaxin were higher in cohort A compared to cohort B. Patients with response in cohort A appeared to have high levels of eotaxin. Symbols reflect unique patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e90bf3a99b282d6101b16dbf2ae9740
https://doi.org/10.1158/1078-0432.22476707.v1
https://doi.org/10.1158/1078-0432.22476707.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
TRAE (grade {greater than or equal to}2 events or grade 1 events occurring in {greater than or equal to}2 patients)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3313859f81fd3b510958a2c88f888a
https://doi.org/10.1158/1078-0432.22476695
https://doi.org/10.1158/1078-0432.22476695
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
TEAE (grade {greater than or equal to}2 events or grade 1 events occurring in {greater than or equal to}2 patients)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2527cd3dedbe0fd4b14c3bd8fa5cbaaa
https://doi.org/10.1158/1078-0432.22476692.v1
https://doi.org/10.1158/1078-0432.22476692.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Per patient description of site of RT, response in irradiated volume, and baseline sum of target irradiated volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4cefa042bfc8b391d7d71ff07607ea
https://doi.org/10.1158/1078-0432.22476698
https://doi.org/10.1158/1078-0432.22476698
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Timeline of Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f540ab30dc596d94264e1440d6d51d
https://doi.org/10.1158/1078-0432.22476713.v1
https://doi.org/10.1158/1078-0432.22476713.v1
Autor:
Paul B. Chapman, Yuval Elhanati, Kristen Aufiero Ramirez, Toni Ricciardi, Aileen Ryan, Mary J. Macri, Sunil Reddy, Alexander N. Shoushtari, Christopher A. Barker, Katherine S. Panageas, Margaret K. Callahan, Kenya P. Vado, Paul Schwarzenberger, Ralph Venhaus, Phillip Wong, Susan J. Knox, Vikram Mavinkurve, Danielle McCabe, Priyanka B. Subrahmanyam, Debra A. Goldman, Darragh Halpenny, Parisa Momtaz, Holden T. Maecker, Michael A. Postow, Jedd D. Wolchok
Publikováno v:
Clin Cancer Res
Purpose:Preclinical data suggest that radiotherapy (RT) is beneficial in combination with immune checkpoint blockade. Clinical trials have explored RT with single-agent immune checkpoint blockade, but no trials have reported RT with the combination o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e5e91ffa3a11b383585fb744856778
https://pubmed.ncbi.nlm.nih.gov/32205463
https://pubmed.ncbi.nlm.nih.gov/32205463
Autor:
Ninh M. La-Beck, Laurence M. Wood, Hossein Mansouri, Alberto Gabizon, Manoj K. Sabnani, Robin Rajan, Alexander D. Le, Hilary Shmeeda, Vikram Mavinkurve, Sandrine Bonkoungou
Publikováno v:
Journal of Controlled Release. 271:139-148
Liposomal nanoparticles are the most commonly used drug nano-delivery platforms. However, recent reports show that certain pegylated liposomal nanoparticles (PLNs) and polymeric nanoparticles have the potential to enhance tumor growth and inhibit ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e0f5b1a49dd8c85d64cea5de2b111f
https://doi.org/10.1016/j.jconrel.2017.12.023
https://doi.org/10.1016/j.jconrel.2017.12.023